Related Experiment Videos
Risk factors evaluation in some cardiovascular diseases
R R Puniyani1, R Ajmani, P A Kale
1School of Biomedical Engineering, Indian Institute of Technology, Powai, Bombay.
Summary
Cardiovascular disease risk is linked to altered blood flow. This study found hypertension, coronary heart disease, and myocardial infarct patients exhibit significant changes in blood viscosity and red cell properties, impacting blood fluidity.
Area of Science:
- Cardiovascular Medicine
- Biophysics
- Haemorheology
Background:
- Cardiovascular risk factors are linked to impaired blood fluidity.
- Blood rheology, influenced by internal organization and various parameters, offers potential for diagnostic and prognostic profiling.
Purpose of the Study:
- To investigate haemorheological parameters in patients undergoing treatment for hypertension, coronary heart disease, and myocardial infarct.
- To evaluate cardiovascular risk based on specific blood rheology markers.
Main Methods:
- Assessment of plasma viscosity, whole blood viscosity, haematocrit, red cell aggregation, and red cell deformation.
- Comparative analysis of these parameters across patient groups with hypertension, coronary heart disease, and myocardial infarct.
Main Results:
- Hypertension patients showed increased plasma viscosity, whole blood viscosity, and red cell aggregation, with decreased red cell deformability.
- Coronary heart disease patients exhibited elevated plasma viscosity and red cell aggregation.
- Myocardial infarct patients, representing a more severe condition, displayed significant increases in both plasma and whole blood viscosity.
- Haematocrit levels remained unaffected across all studied groups.
Conclusions:
- Haemorheological alterations are significant in patients with hypertension, coronary heart disease, and myocardial infarct.
- Specific changes in blood viscosity and red cell properties correlate with the severity of cardiovascular conditions.
- These rheological parameters hold potential for diagnostic and prognostic applications in cardiovascular disease management.